Literature DB >> 8809970

Appropriate therapeutic use of immunoglobulin.

E R Stiehm1.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8809970     DOI： 10.1016/s0887-7963(96)80060-5

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN： 0887-7963


× No keyword cloud information.
  3 in total

Review 1.  Passive immunity in prevention and treatment of infectious diseases.

Authors:  M A Keller; E R Stiehm
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Flebogamma(®) 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases.

Authors:  Mark Ballow; Paul J Pinciaro; Timothy Craig; Gary Kleiner; James Moy; Hans D Ochs; John Sleasman; William Smits
Journal:  J Clin Immunol       Date:  2016-06-08       Impact factor: 8.317

Review 3.  Manufacture of immunoglobulin products for patients with primary antibody deficiencies - the effect of processing conditions on product safety and efficacy.

Authors:  Albert Farrugia; Isabella Quinti
Journal:  Front Immunol       Date:  2014-12-23       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.